Arrowhead Pharmaceuticals, a leader in RNAi therapeutics, reported a significant insider sale amid a year of exceptional stock gains.

Arrowhead Pharmaceuticals, Inc. today announced interim results from two Phase 1/2a clinical trials of ARO-INHBE and ARO-ALK7, the company's investigational RNA interference (RNAi) therapeutics being ...

In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases, oncology, and preventive vaccines. A recent article ...

Silexion Therapeutics ( ($SLXN) ) has shared an announcement. On January 6, 2026, Silexion Therapeutics released a CEO letter to shareholders ...

Transverse tubules (T-tubules) play significant role in muscle contraction. However, the underlying mechanism of their ...

Linkage Global Inc. announced at the 2026 Consumer Electronics Show (CES) that it has entered strategic intellectual property partnerships with premium headphone brand ClickClack and VIBELENS. Under ...

With a new year just days away, we hope the following list of the top 10 patents of 2025 sparks interest in the state of ...

Detailed price information for Silence Therapeutics Plc ADR (SLN-Q) from The Globe and Mail including charting and trades.

ALMA in Chile receives 145 low-noise amplifiers for Band 2, enabling detailed studies of cold interstellar gas, planet-forming disks, and organic molecules in nearby galaxies.

The National Testing Agency (NTA) has issued the subject wise NEET 2026 syllabus on this website soon after the NMC released ...

Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the ...

Transverse tubules (T-tubules) play significant role in muscle contraction. However, the underlying mechanism of their ...